Nuvo announced the availability of its FDA-cleared INVU™ wearable solution, a cloud-based pregnancy monitoring platform that enables expectant mothers to access medical-grade monitoring from home or work through their healthcare provider. Offered on a flexible prescription-based model, the solution expands access to advanced prenatal care without requiring long-term ownership or significant upfront cost.
By shifting pregnancy monitoring beyond traditional in-clinic visits, INVU™ addresses a longstanding gap in maternal care—limited visibility into maternal and fetal well-being between appointments. The wearable allows continuous, clinician-connected monitoring, providing reassurance and enhanced oversight, particularly for high-risk pregnancies or patients seeking greater peace of mind.
Developed over more than a decade, INVU™ combines a medical-grade wearable with cloud-based analytics and secure infrastructure to deliver real-time maternal and fetal insights. This approach establishes a new category in obstetrics—one that aligns accessibility, convenience, and connectivity with the clinical rigor required in modern pregnancy care.